To determine what extent of GBMs are dependent on the CD44v6/AKT pathway and the mechanisms underlying the interaction between CD44v6 and AKT, future studies with larger numbers of GBM specimens and other ligands of CD44v6 will be required. Here, AKT1 is linked to glioblastoma.